| Outcome Measures: |
Primary: OBJECTIVE PARAMETERS, 1. Blood sugar fasting in Milligrams per decilitre, Change from Baseline at End of trial [3 month]|OBJECTIVE PARAMETERS, Blood sugar post prandial Milligrams per decilitre, Change from Baseline at End of trial [3 month]|OBJECTIVE PARAMETERS, Glycosylated Haemoglobin (HbA1c in %), Change from Baseline at End of trial [3 month] | Secondary: SUBJECTIVE PARAMETERS, Polyurea (excessive urine) grading from 0 to 3, Change from Baseline at End of trial [3 month]|SUBJECTIVE PARAMETERS, Unclear / turbid urine grading from 0 to 3, Change from Baseline at End of trial [3 month]|SUBJECTIVE PARAMETERS, Polyphagia( excessive hunger) grading from 0 to 3, Change from Baseline at End of trial [3 month]|SUBJECTIVE PARAMETERS, Polydipsia (excessive thirst) grading from 0 to 3, Change from Baseline at End of trial [3 month]|SUBJECTIVE PARAMETERS, Exhaustion / tiredness grading from 0 to 3, Change from Baseline at End of trial [3 month]|SUBJECTIVE PARAMETERS, Polyneuritis (numbness / tingling/ burning of soles) grading from 0 to 3, Change from Baseline at End of trial [3 month]|SUBJECTIVE PARAMETERS, Cramps while walking/calf muscle pain grading from 0 to 3, Change from Baseline at End of trial [3 month]|SUBJECTIVE PARAMETERS, Constipation grading from 0 to 3, Change from Baseline at End of trial [3 month]|SUBJECTIVE PARAMETERS, Excessive Sweating grading from 0 to 3, Change from Baseline at End of trial [3 month]|SUBJECTIVE PARAMETERS, Excessive Sleeping grading from 0 to 3, Change from Baseline at End of trial [3 month]|SUBJECTIVE PARAMETERS, DSQ grading from 0 to 3, Change from Baseline at End of trial [3 month]
|
